Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 9 | 2023 | 1161 | 1.630 |
Why?
|
| Lymphatic Abnormalities | 5 | 2024 | 35 | 1.470 |
Why?
|
| Surgeons | 4 | 2023 | 249 | 1.460 |
Why?
|
| Burnout, Professional | 5 | 2021 | 113 | 1.200 |
Why?
|
| Hemangioma | 5 | 2024 | 95 | 1.190 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 503 | 1.100 |
Why?
|
| Sirolimus | 3 | 2024 | 220 | 0.960 |
Why?
|
| Splenectomy | 2 | 2015 | 60 | 0.950 |
Why?
|
| Biliary Dyskinesia | 1 | 2024 | 5 | 0.940 |
Why?
|
| Cholecystectomy | 1 | 2024 | 55 | 0.910 |
Why?
|
| Vascular Malformations | 2 | 2022 | 81 | 0.870 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 50 | 0.830 |
Why?
|
| Hirschsprung Disease | 4 | 2024 | 35 | 0.770 |
Why?
|
| Colectomy | 3 | 2024 | 75 | 0.680 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 207 | 0.660 |
Why?
|
| Postoperative Complications | 8 | 2024 | 3020 | 0.650 |
Why?
|
| Registries | 3 | 2017 | 1398 | 0.630 |
Why?
|
| Ovarian Cysts | 1 | 2019 | 24 | 0.630 |
Why?
|
| Infant | 22 | 2024 | 12376 | 0.600 |
Why?
|
| Sclerotherapy | 4 | 2024 | 40 | 0.600 |
Why?
|
| Leadership | 1 | 2020 | 226 | 0.600 |
Why?
|
| Ileostomy | 1 | 2018 | 26 | 0.590 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 227 | 0.560 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 28 | 0.540 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 34 | 0.540 |
Why?
|
| Child | 29 | 2024 | 24256 | 0.530 |
Why?
|
| Embolization, Therapeutic | 2 | 2016 | 226 | 0.520 |
Why?
|
| Infant, Newborn | 16 | 2024 | 8114 | 0.510 |
Why?
|
| Hemangioma, Capillary | 1 | 2015 | 17 | 0.500 |
Why?
|
| Humans | 56 | 2024 | 123262 | 0.480 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 1312 | 0.470 |
Why?
|
| Spleen | 1 | 2015 | 272 | 0.470 |
Why?
|
| Leukemia, Myeloid | 1 | 2014 | 85 | 0.460 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 429 | 0.460 |
Why?
|
| Nephrectomy | 1 | 2015 | 173 | 0.440 |
Why?
|
| Neonatal Screening | 1 | 2015 | 184 | 0.440 |
Why?
|
| Myeloproliferative Disorders | 1 | 2014 | 86 | 0.440 |
Why?
|
| Retrospective Studies | 20 | 2024 | 16069 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2014 | 137 | 0.430 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 236 | 0.410 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1013 | 0.410 |
Why?
|
| Treatment Outcome | 13 | 2024 | 12170 | 0.370 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 27 | 0.370 |
Why?
|
| General Surgery | 1 | 2013 | 203 | 0.360 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 270 | 0.330 |
Why?
|
| Databases, Factual | 6 | 2016 | 1171 | 0.330 |
Why?
|
| Adolescent | 14 | 2024 | 19127 | 0.330 |
Why?
|
| Female | 28 | 2024 | 65618 | 0.320 |
Why?
|
| Risk Assessment | 2 | 2015 | 3336 | 0.310 |
Why?
|
| Child, Preschool | 13 | 2023 | 13918 | 0.300 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 798 | 0.300 |
Why?
|
| Anus, Imperforate | 2 | 2024 | 20 | 0.290 |
Why?
|
| Survival Rate | 4 | 2015 | 2002 | 0.280 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 904 | 0.270 |
Why?
|
| Male | 26 | 2024 | 60334 | 0.270 |
Why?
|
| Evidence-Based Medicine | 3 | 2024 | 623 | 0.260 |
Why?
|
| Abnormalities, Multiple | 3 | 2024 | 962 | 0.260 |
Why?
|
| Thoracic Duct | 2 | 2016 | 6 | 0.250 |
Why?
|
| Lymphography | 2 | 2016 | 12 | 0.250 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 3677 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 679 | 0.240 |
Why?
|
| United States | 8 | 2021 | 10654 | 0.240 |
Why?
|
| Anorectal Malformations | 1 | 2024 | 12 | 0.230 |
Why?
|
| Gastroschisis | 1 | 2024 | 52 | 0.220 |
Why?
|
| Job Satisfaction | 2 | 2021 | 78 | 0.220 |
Why?
|
| Personal Satisfaction | 2 | 2021 | 102 | 0.220 |
Why?
|
| Ultrasonography | 2 | 2019 | 942 | 0.210 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2024 | 83 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 202 | 0.210 |
Why?
|
| Colostomy | 1 | 2022 | 26 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 1211 | 0.210 |
Why?
|
| Enterocolitis | 1 | 2023 | 25 | 0.200 |
Why?
|
| Reoperation | 2 | 2016 | 819 | 0.200 |
Why?
|
| Accreditation | 2 | 2013 | 81 | 0.200 |
Why?
|
| Pneumothorax | 1 | 2023 | 80 | 0.200 |
Why?
|
| Foreign Bodies | 2 | 2020 | 104 | 0.190 |
Why?
|
| Incidence | 3 | 2024 | 3054 | 0.190 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 160 | 0.190 |
Why?
|
| Neuroblastoma | 2 | 2017 | 519 | 0.180 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 781 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 610 | 0.180 |
Why?
|
| Appendicitis | 1 | 2022 | 128 | 0.180 |
Why?
|
| Magnets | 1 | 2020 | 22 | 0.180 |
Why?
|
| Hospitals | 1 | 2023 | 392 | 0.180 |
Why?
|
| Lymphangioma | 1 | 2020 | 22 | 0.180 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 37 | 0.170 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2021 | 239 | 0.170 |
Why?
|
| Down Syndrome | 1 | 2023 | 195 | 0.170 |
Why?
|
| Parental Leave | 1 | 2019 | 4 | 0.170 |
Why?
|
| Algorithms | 2 | 2019 | 1598 | 0.160 |
Why?
|
| Harassment, Non-Sexual | 1 | 2019 | 1 | 0.160 |
Why?
|
| Incivility | 1 | 2019 | 2 | 0.160 |
Why?
|
| Career Choice | 1 | 2020 | 142 | 0.160 |
Why?
|
| Constipation | 1 | 2020 | 113 | 0.160 |
Why?
|
| Prejudice | 1 | 2019 | 38 | 0.160 |
Why?
|
| Medical Errors | 2 | 2021 | 155 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2019 | 32 | 0.160 |
Why?
|
| Fecal Incontinence | 1 | 2019 | 69 | 0.160 |
Why?
|
| Gestational Age | 3 | 2024 | 1137 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 309 | 0.150 |
Why?
|
| Organizational Culture | 1 | 2019 | 94 | 0.150 |
Why?
|
| Injury Severity Score | 2 | 2016 | 220 | 0.150 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 97 | 0.150 |
Why?
|
| Ontario | 1 | 2018 | 64 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1006 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 197 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3384 | 0.140 |
Why?
|
| Pregnancy | 4 | 2024 | 7129 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5056 | 0.140 |
Why?
|
| Shorthand | 1 | 2016 | 1 | 0.140 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.140 |
Why?
|
| Aggression | 1 | 2019 | 224 | 0.140 |
Why?
|
| Surgical Stomas | 1 | 2016 | 8 | 0.140 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 35 | 0.140 |
Why?
|
| Aircraft | 1 | 2016 | 19 | 0.140 |
Why?
|
| Air Ambulances | 1 | 2016 | 26 | 0.140 |
Why?
|
| Patient Acuity | 1 | 2016 | 63 | 0.130 |
Why?
|
| Patient Handoff | 1 | 2016 | 26 | 0.130 |
Why?
|
| Chylothorax | 1 | 2016 | 27 | 0.130 |
Why?
|
| Age of Onset | 1 | 2018 | 581 | 0.130 |
Why?
|
| Workplace | 1 | 2017 | 69 | 0.130 |
Why?
|
| Wilms Tumor | 1 | 2017 | 113 | 0.130 |
Why?
|
| Mentoring | 1 | 2017 | 75 | 0.130 |
Why?
|
| Wounds, Penetrating | 1 | 2016 | 140 | 0.130 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2015 | 9 | 0.130 |
Why?
|
| Abbreviated Injury Scale | 1 | 2015 | 8 | 0.130 |
Why?
|
| Mentors | 1 | 2017 | 143 | 0.130 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2015 | 17 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2013 | 972 | 0.130 |
Why?
|
| Head Protective Devices | 1 | 2015 | 24 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2017 | 164 | 0.120 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 144 | 0.120 |
Why?
|
| Device Removal | 1 | 2017 | 222 | 0.120 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 8 | 0.120 |
Why?
|
| Risk Factors | 4 | 2024 | 10035 | 0.120 |
Why?
|
| Bicycling | 1 | 2015 | 39 | 0.120 |
Why?
|
| Adrenalectomy | 1 | 2015 | 36 | 0.120 |
Why?
|
| Hypoalbuminemia | 1 | 2014 | 18 | 0.120 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 203 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1414 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 209 | 0.120 |
Why?
|
| Massachusetts | 1 | 2014 | 124 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 196 | 0.120 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 65 | 0.120 |
Why?
|
| Time Factors | 3 | 2024 | 6223 | 0.120 |
Why?
|
| Safety | 1 | 2015 | 218 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2014 | 247 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2015 | 136 | 0.110 |
Why?
|
| Physicians | 2 | 2017 | 581 | 0.110 |
Why?
|
| Bleomycin | 1 | 2014 | 150 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 107 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 127 | 0.110 |
Why?
|
| Gadolinium | 1 | 2014 | 103 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 2114 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1342 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 150 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2015 | 304 | 0.110 |
Why?
|
| Ampulla of Vater | 1 | 2013 | 16 | 0.110 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2013 | 9 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2024 | 117 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 364 | 0.100 |
Why?
|
| Adult | 7 | 2024 | 29100 | 0.100 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2013 | 23 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 340 | 0.100 |
Why?
|
| Medicaid | 1 | 2015 | 244 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 221 | 0.100 |
Why?
|
| Cloaca | 2 | 2024 | 15 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 2398 | 0.100 |
Why?
|
| Body Weight | 1 | 2016 | 1007 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1253 | 0.100 |
Why?
|
| Urogenital Abnormalities | 2 | 2024 | 169 | 0.100 |
Why?
|
| Aged | 5 | 2016 | 19198 | 0.100 |
Why?
|
| SELEX Aptamer Technique | 1 | 2011 | 5 | 0.090 |
Why?
|
| Syndrome | 2 | 2024 | 1116 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2012 | 110 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2012 | 101 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 264 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 282 | 0.090 |
Why?
|
| Anemia | 1 | 2014 | 341 | 0.090 |
Why?
|
| Spinal Dysraphism | 1 | 2014 | 265 | 0.090 |
Why?
|
| Comorbidity | 1 | 2015 | 1497 | 0.090 |
Why?
|
| Contrast Media | 1 | 2014 | 471 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2013 | 323 | 0.090 |
Why?
|
| Middle Aged | 5 | 2016 | 26091 | 0.080 |
Why?
|
| DNA | 1 | 2015 | 1594 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1078 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 351 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2058 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2854 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2024 | 1239 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 4701 | 0.060 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 33 | 0.060 |
Why?
|
| Anal Canal | 1 | 2024 | 78 | 0.060 |
Why?
|
| Rectum | 1 | 2024 | 97 | 0.050 |
Why?
|
| Neck | 1 | 2024 | 138 | 0.050 |
Why?
|
| Hernia, Umbilical | 1 | 2024 | 41 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2023 | 624 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2023 | 36 | 0.050 |
Why?
|
| Spine | 1 | 2024 | 143 | 0.050 |
Why?
|
| Biological Factors | 1 | 2023 | 28 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2023 | 54 | 0.050 |
Why?
|
| Public Opinion | 1 | 2023 | 56 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2024 | 180 | 0.050 |
Why?
|
| Scoliosis | 1 | 2024 | 134 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2024 | 294 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2023 | 108 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 263 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2023 | 110 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 249 | 0.050 |
Why?
|
| Mutation | 1 | 2015 | 5767 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2020 | 20 | 0.040 |
Why?
|
| Empathy | 1 | 2021 | 57 | 0.040 |
Why?
|
| Pelvic Floor | 1 | 2020 | 33 | 0.040 |
Why?
|
| Appendectomy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Patient Safety | 2 | 2016 | 397 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 100 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 580 | 0.040 |
Why?
|
| Adoption | 1 | 2019 | 16 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 2019 | 33 | 0.040 |
Why?
|
| Program Development | 1 | 2020 | 187 | 0.040 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 36 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1418 | 0.040 |
Why?
|
| Policy Making | 1 | 2019 | 59 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3549 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 373 | 0.040 |
Why?
|
| Colon | 1 | 2021 | 352 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 333 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2019 | 220 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 712 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 482 | 0.030 |
Why?
|
| Lymphangiectasis | 1 | 2016 | 2 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 448 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2844 | 0.030 |
Why?
|
| Bronchitis | 1 | 2016 | 34 | 0.030 |
Why?
|
| Punctures | 1 | 2016 | 55 | 0.030 |
Why?
|
| Intestinal Perforation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 194 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 300 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 132 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 140 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 571 | 0.030 |
Why?
|
| Selection Bias | 1 | 2015 | 20 | 0.030 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 31 | 0.030 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2015 | 38 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 39 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 339 | 0.030 |
Why?
|
| Cholestasis | 1 | 2016 | 148 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 142 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 105 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 74 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1100 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 297 | 0.030 |
Why?
|
| Phenotype | 1 | 2024 | 4228 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 243 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1878 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 605 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 195 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 152 | 0.030 |
Why?
|
| Learning | 1 | 2017 | 361 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 754 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 126 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 655 | 0.030 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 323 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 322 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 747 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2016 | 378 | 0.030 |
Why?
|
| North Carolina | 1 | 2012 | 58 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6030 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1245 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1304 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 814 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 644 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1218 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 577 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1933 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1584 | 0.020 |
Why?
|
| Workload | 1 | 2012 | 147 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1167 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 154 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 592 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3239 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 862 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1389 | 0.020 |
Why?
|
| Young Adult | 1 | 2023 | 8867 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2811 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1232 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3666 | 0.020 |
Why?
|
| Communication | 1 | 2012 | 514 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1201 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 4511 | 0.020 |
Why?
|
| Animals | 2 | 2014 | 33852 | 0.010 |
Why?
|